Black Rock Inc. Omeros Corp Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Omeros Corp stock. As of the latest transaction made, Black Rock Inc. holds 4,211,122 shares of OMER stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,211,122

Previous 4,279,836 1.61%

Holding current value

$17.1 Million

Previous $14 Million 3.81%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.88 - $4.89 $197,896 - $336,011	-68,714 Reduced 1.61%	4,211,122 $14.5 Million
Q4 2023 Feb 13, 2024	BUY	$1.08 - $3.63 $274,842 - $923,776	254,484 Added 6.32%	4,279,836 $14 Million
Q3 2023 Nov 13, 2023	SELL	$2.81 - $5.69 $364,176 - $737,424	-129,600 Reduced 3.12%	4,025,352 $11.8 Million
Q2 2023 Aug 11, 2023	BUY	$4.45 - $7.57 $13.3 Million - $22.7 Million	2,994,468 Added 258.04%	4,154,952 $22.6 Million
Q1 2023 May 12, 2023	BUY	$2.48 - $5.22 $52,952 - $111,457	21,352 Added 1.87%	1,160,484 $5.4 Million

Q4 2022 Feb 13, 2023	SELL	$1.75 - $3.96 $1,996 - $4,518	-1,141 Reduced 0.1%	1,139,132 $2.57 Million
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $269,667 - $651,041	-87,271 Reduced 7.11%	1,140,273 $3.59 Million
Q2 2022 Aug 12, 2022	SELL	$1.92 - $6.28 $5.45 Million - $17.8 Million	-2,837,857 Reduced 69.81%	1,227,544 $3.38 Million
Q1 2022 May 12, 2022	BUY	$5.07 - $7.2 $77,941 - $110,685	15,373 Added 0.38%	4,065,401 $24.4 Million
Q4 2021 Feb 10, 2022	SELL	$5.67 - $8.54 $2.7 Million - $4.06 Million	-475,472 Reduced 10.51%	4,050,028 $26 Million
Q3 2021 Nov 09, 2021	SELL	$13.4 - $16.3 $546,009 - $664,176	-40,747 Reduced 0.89%	4,525,500 $62.4 Million
Q2 2021 Aug 11, 2021	BUY	$14.81 - $19.13 $67.6 Million - $87.4 Million	4,566,247 New	4,566,247 $67.8 Million

Others Institutions Holding OMER

# of Institutions

107

Shares Held

26M

Call Options Held

299K

Put Options Held

520K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $255M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account